
Rhizome AI YC Başvurusu
Rhizome AI, B2B şirketi olarak Winter 2026 grubunda Y Combinator'dan geçti. Aşağıda: şirketin ne yaptığı, kimin kurduğu ve gerçek YC formunda yeniden yapılandırılmış YC başvurusu.
- YC grubu
- Winter 2026
- Sektör
- B2B
- Ekip büyüklüğü
- 1
- Durum
- Active
- Lansmanı Yapıldı
- 2026
Kurucular
Chetan MishraFounder
Rhizome AI ne yapar
It takes 500,000 days of office work to bring a drug to market. We want to make it 5. To get there, we need agents doing most of the work. Today, our research agent is the best way to know what the FDA thinks. Users ask a question and get an answer backed by up to 1,000 documents, where each statement has a citation. It’s the best because we have the best retrieval engine. We’ve tuned it on our life science-specific dataset, and we find what others miss. As more teams use Rhizome, we gain more data on what regulatory professionals actually need, which makes retrieval even better. This flywheel is how we become the retrieval engine that powers all human and agent work in life sciences. Chetan started his career as a research engineer, but quickly realized he enjoyed building more than research. He joined EvolutionaryScale as their sole founding product engineer, launching their developer-scientist platform and scaling to tens of thousands of users and billions of API calls. He was also #16 at Instabase helping banks with document processing, closing $7m as the technical closer. Agents can do magical things today, but most in life sciences only use them to edit emails. Agents are missing the context they need to 100x the number of drugs we can bring to market. Rhizome AI is focused on that critical problem.
Rhizome AI'in YC başvurusu, yeniden yapılandırılmış
Y Combinator başvurusu
Rhizome AI, Winter 2026 dönemi. Gerçek form soruları, herkese açık verilerden yanıtlandı.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Rhizome AI
Agent Platform for Life Sciences
We built a research agent that helps regulatory professionals understand FDA guidance by answering their questions with citations from up to 1,000 relevant documents. It's powered by a retrieval engine tuned specifically on life science datasets that finds regulatory information others miss. Our product aims to automate much of the work involved in navigating drug approval processes.
I live in New York City and the company is based there and remotely distributed.
New York is a major life sciences hub, and remote lets us access talent and customers globally. This fits our need to stay close to regulatory experts and life sciences teams while keeping flexibility.
Tam başvuruda 21 ek cevap
Founders, Progress, Idea, Equity, Curious, Batch Preference tam sürümde. YC Insights'ta, diğer her YC grubu yanında açmak için ücretsiz bir hesap oluşturun.
Sıkça Sorulan Sorular
Bu, Rhizome AI şirketinin gerçek YC başvurusu mu?
Hayır. Y Combinator gönderilen başvuruları gizli tutar. Bu bir yeniden yapılandırmadır: gerçek YC form soruları, Rhizome AI'in kamuya açık verilerinden (lansman notları, kurucu geçmişleri, ürün açıklaması) yanıtlanmıştır. Rhizome AI gibi bir şirketin YC'ye kendisini nasıl sunacağını gösterir, gönderdikleri metni değil.
Rhizome AI hangi YC grubundaydı?
Rhizome AI, Y Combinator Winter 2026 grubundaydı.
Rhizome AI kim tarafından kuruldu?
Rhizome AI, Chetan Mishra tarafından kuruldu.
Rhizome AI ne iş yapar?
Agent Platform for Life Sciences
Tam yeniden oluşturulmuş başvuruyu nasıl okurum?
Ücretsiz bir Round Funded hesabı oluşturun. Rhizome AI'ın başvurusunun tam 26 soruluk versiyonu ve diğer tüm YC batch'leri YC Insights'ta.